Trends in Hydroxyurea Utilization for the Treatment of Sickle Cell Anemia in Florida

被引：1
|
作者：
Black, Vandy [1 ]
Mack, Jasmine A. [2 ,3 ]
Hall, Jaclyn [2 ,3 ]
Morris, Heather [2 ,3 ]
Shenkman, Elizabeth [2 ,3 ]
Gurka, Matthew J. [2 ,3 ]
机构：
[1] Univ Florida, Coll Med, Dept Pediat, Div Pediat Hematol & Oncol, Gainesville, FL USA
[2] Univ Florida, Coll Med, Dept Hlth Outcomes & Biomed Informat, Gainesville, FL USA
[3] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-125799
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2293
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Adherence to Hydroxyurea Therapy in Children with Sickle Cell Anemia
    Thornburg, Courtney D.
    Calatroni, Agustin
    Telen, Marilyn
    Kemper, Alex R.
    JOURNAL OF PEDIATRICS, 2010, 156 (03): : 415 - 419
  • [42] Hydroxyurea Reduces the Hypercoagulable State In Sickle Cell Anemia
    Colella, Marina P.
    Machado-Neto, Joao
    Quaino, Susan K. P.
    Conran, Nicola
    Annichino-Bizzacchi, Joyce M.
    Costa, Fernando Ferreira
    Saad, Sara Olalla
    de Paula, Erich V.
    Traina, Fabiola
    BLOOD, 2011, 118 (21) : 492 - 492
  • [43] Hydroxyurea and sickle cell anemia: effect on quality of life
    Ballas, Samir K.
    Barton, Franca B.
    Waclawiw, Myron A.
    Swerdlow, Paul
    Eckman, James R.
    Pegelow, Charles H.
    Koshy, Mabel
    Barton, Bruce A.
    Bonds, Duane R.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2006, 4 (1)
  • [44] Cost-effectiveness of hydroxyurea in sickle cell anemia
    Moore, RD
    Charache, S
    Terrin, ML
    Barton, FB
    Ballas, SK
    AMERICAN JOURNAL OF HEMATOLOGY, 2000, 64 (01) : 26 - 31
  • [45] Hydroxyurea and sickle cell anemia: effect on quality of life
    Samir K Ballas
    Franca B Barton
    Myron A Waclawiw
    Paul Swerdlow
    James R Eckman
    Charles H Pegelow
    Mabel Koshy
    Bruce A Barton
    Duane R Bonds
    Health and Quality of Life Outcomes, 4
  • [46] Fixed low-dose hydroxyurea for the treatment of adults with sickle cell anemia in Nigeria
    Tayo, Bamidele O.
    Akingbola, Titilola S.
    Saraf, Santosh L.
    Shah, Binal N.
    Ezekekwu, Chinedu A.
    Sonubi, Omowunmi
    Hsu, Lewis L.
    Cooper, Richard S.
    Gordeuk, Victor R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (08) : E193 - E196
  • [47] Advanced clinical parameters: A complementary hydroxyurea adherence evaluation in sickle cell anemia treatment
    Moreira, Isabela Delfino
    Machado Lessa, Carem Luana
    Goncalves Rocha, Gueverson Leonardo
    Schmitz, Laura Dewes
    Jahnke, Viviane Schmitt
    Fogliatto, Laura Maria
    Werlang, Maria Cristina
    Rotta, Liane Nanci
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (06) : 736 - 748
  • [48] Changing the Clinical Paradigm of Hydroxyurea Treatment for Sickle Cell Anemia Through Precision Medicine
    Dong, Min
    McGann, Patrick T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (01) : 73 - 81
  • [49] Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia
    Walker, Aisha L.
    Steward, Shirley
    Howard, Thad A.
    Mortier, Nicole
    Smeltzer, Matthew
    Wang, Yong-Dong
    Ware, Russell E.
    BLOOD, 2011, 118 (20) : 5664 - 5670
  • [50] Brain MRI/MRA Findings after Hydroxyurea Treatment in Children with Sickle Cell Anemia
    Nottage, Kerri
    Ware, Russell E.
    Smeltzer, Matthew P.
    Dowdy, Jola
    Wang, Winfred C.
    Hankins, Jane S.
    Helton, Kathleen J.
    Aygun, Banu
    BLOOD, 2014, 124 (21)
12345